Bharat Biotech stated that it has submitted application for WHO Emergency Use Listing (EUL) for Covaxin, and regulatory approvals are expected in July-September, 2021.

The company said it has obtained emergency use authorisations in 13 countries.

The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.

Most countries recommend vaccinations against Covid-19. Unvaccinated travellers can travel with negative RT-PCR tests prior to travel, in the absence of any other country-specific travel restrictions, the company said.